Zylox-Tonbridge Buys Back 0.06 Million H Shares for HK$1.15 Million, Treasury Stock Rises to 12.75 Million

Bulletin Express

Jul 14

Zylox-Tonbridge Medical Technology Co., Ltd. repurchased 59,000 H shares on 14 July 2026 via on-market transactions, paying an aggregate HK$1.15 million at prices ranging from HK$19.00 to HK$19.57 per share. The weighted-average repurchase price was HK$19.43.

Following the transaction, issued H shares (excluding treasury shares) slipped from 323.66 million to 323.60 million, trimming the free float by 0.02%. Total issued share capital remains unchanged at 336.35 million shares, while the company’s treasury stock balance increased from 12.69 million to 12.75 million shares.

The buyback forms part of the mandate approved on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.60 million shares, equivalent to 1.08% of the share count on the mandate date. A 30-day moratorium on new share issues or treasury share disposals is in place until 13 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1125876046"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1125876046\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1125876046?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125876046","market":"hk","top_or_hot":-1,"title":"Zylox-Tonbridge Buys Back 0.06 Million H Shares for HK$1.15 Million, Treasury Stock Rises to 12.75 Million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. repurchased 59,000 H shares on 14 July 2026 via on-market transactions, paying an aggregate HK$1.15 million at prices ranging from HK$19.00 to HK$19.57 per share. The weighted-average repurchase price was HK$19.43.</p>\n<p>Following the transaction, issued H shares (excluding treasury shares) slipped from 323.66 million to 323.60 million, trimming the free float by 0.02%. Total issued share capital remains unchanged at 336.35 million shares, while the company’s treasury stock balance increased from 12.69 million to 12.75 million shares.</p>\n<p>The buyback forms part of the mandate approved on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.60 million shares, equivalent to 1.08% of the share count on the mandate date. A 30-day moratorium on new share issues or treasury share disposals is in place until 13 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Buys Back 0.06 Million H Shares for HK$1.15 Million, Treasury Stock Rises to 12.75 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Buys Back 0.06 Million H Shares for HK$1.15 Million, Treasury Stock Rises to 12.75 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-14 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. repurchased 59,000 H shares on 14 July 2026 via on-market transactions, paying an aggregate HK$1.15 million at prices ranging from HK$19.00 to HK$19.57 per share. The weighted-average repurchase price was HK$19.43.</p>\n<p>Following the transaction, issued H shares (excluding treasury shares) slipped from 323.66 million to 323.60 million, trimming the free float by 0.02%. Total issued share capital remains unchanged at 336.35 million shares, while the company’s treasury stock balance increased from 12.69 million to 12.75 million shares.</p>\n<p>The buyback forms part of the mandate approved on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.60 million shares, equivalent to 1.08% of the share count on the mandate date. A 30-day moratorium on new share issues or treasury share disposals is in place until 13 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1125876046","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125876046","pubTimestamp":1784026847,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. repurchased 59,000 H shares on 14 July 2026 via on-market transactions, paying an aggregate HK$1.15 million at prices ranging from HK$19.00 to HK$19.57...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"Zylox-Tonbridge以115万港元回购06万股H股，库存股增至1275万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. repurchased 59,000 H shares on 14 July 2026 via on-market transactions, paying an aggregate HK$1.15 million at prices ranging from HK$19.00 to HK$19.57 per share. The weighted-average repurchase price was HK$19.43.\nFollowing the transaction, issued H shares (excluding treasury shares) slipped from 323.66 million to 323.60 million, trimming the free float by 0.02%. Total issued share capital remains unchanged at 336.35 million shares, while the company’s treasury stock balance increased from 12.69 million to 12.75 million shares.\nThe buyback forms part of the mandate approved on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.60 million shares, equivalent to 1.08% of the share count on the mandate date. A 30-day moratorium on new share issues or treasury share disposals is in place until 13 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}